Evidence map›Paper›PMID 39190916›Full record

ArticleJMIR research protocols2024

Enhanced Cohort Methods for HIV Research and Epidemiology (ENCORE): Protocol for a Nationwide Hybrid Cohort for Transgender Women in the United States.

Andrea L Wirtz, Tonia Poteat, Annick Borquez, Sabriya Linton, Megan Stevenson, James Case, Carter Brown, Arianna Lint, Marissa Miller, Asa Radix and 13 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Andrea L WirtzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0002-2063-1534
Tonia PoteatDivision of Healthcare in Adult Populations, Duke University School of Nursing, Durham, NC, United States.ORCID https://orcid.org/0000-0001-6541-3787
Annick BorquezDivision of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, United States.ORCID https://orcid.org/0000-0002-6033-9837
Sabriya LintonDepartment of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.ORCID https://orcid.org/0000-0003-3579-2151
Megan StevensonDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0002-7686-8901
James CaseJohns Hopkins School of Nursing, Baltimore, MD, United States.ORCID https://orcid.org/0000-0001-8014-858X
Carter BrownNational Black Transgender Advocacy Coalition, Carrolton, TX, United States.ORCID https://orcid.org/0000-0002-4591-993X
Arianna LintArianna's Center, Fort Lauderdale, FL, United States.ORCID https://orcid.org/0009-0003-9908-4004
Marissa MillerTrans Solutions Research and Resource Center, Indianapolis, IN, United States.ORCID https://orcid.org/0000-0003-2432-7027
Asa RadixCallen-Lorde Community Health Center, New York, NY, United States.ORCID https://orcid.org/0000-0001-9611-4181
Keri N AlthoffDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0002-5068-6595
Jason S SchneiderDivision of General Internal Medicine, Department of Medicine, Emory University, Atlanta, GA, United States.ORCID https://orcid.org/0000-0002-6265-0370
J Sonya HawDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University, Atlanta, GA, United States.ORCID https://orcid.org/0000-0003-3405-8609
Andrew J WawrzyniakDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID https://orcid.org/0000-0002-1780-0966
Allan RodriguezDivision of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID https://orcid.org/0000-0001-9477-3327
Erin CooneyDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0001-9563-1822
Elizabeth HumesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0000-0003-3432-7688
Ceza PontesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0009-0004-2453-213X
Shannon SeopaulDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0009-0003-4033-8727
Camille WhiteDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.ORCID https://orcid.org/0009-0002-4568-9692
Chris BeyrerDuke Global Health Institute, Duke University, Durham, NC, United States.ORCID https://orcid.org/0000-0003-0665-9124
Sari L ReisnerDepartment of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MD, United States.ORCID https://orcid.org/0000-0001-7868-4746
ENCORE Study GroupSee Acknowledgments, .

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
Enhanced Cohort methods for HIV Research and Epidemiology (ENCORE) in the United StatesR01AI172092 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COONEY, ERIN EILEEN, REISNER, SARI · 2022 to 2025
$7.1M
NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI064518NIAID NIH HHS P30 AI073961NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI172092
6 · The paper itself

Abstract

backgroundIn the United States, transgender women are disproportionately impacted by HIV and prioritized in the national strategy to end the epidemic. Individual, interpersonal, and structural vulnerabilities underlie HIV acquisition among transgender women and fuel syndemic conditions, yet no nationwide cohort monitors their HIV and other health outcomes.

objectiveOur objective is to develop a nationwide cohort to estimate HIV incidence, identify risk factors, and investigate syndemic conditions co-occurring with HIV vulnerability or acquisition among US transgender women. The study is informed by the Syndemics Framework and the Social Ecological Model, positing that stigma-related conditions are synergistically driven by shared multilevel vulnerabilities.

methodsTo address logistical and cost challenges while minimizing technology barriers and research distrust, we aim to establish a novel, hybrid community hub-supported digital cohort (N=3000). The digital cohort is the backbone of the study and is enhanced by hubs strategically located across the United States for increased engagement and in-person support. Study participants are English or Spanish speakers, are aged ≥18 years, identify as transgender women or along the transfeminine spectrum, reside in 1 of the 50 states or Puerto Rico, and do not have HIV (laboratory confirmed). Participants are followed for 24 months, with semiannual assessments. These include a questionnaire and laboratory-based HIV testing using self-collected specimens. Using residential zip codes, person-level data will be merged with contextual geolocated data, including population health measures and economic, housing, and other social and structural factors. Analyses will (1) evaluate the contribution of hub support to the digital cohort using descriptive statistics; (2) estimate and characterize syndemic patterns among transgender women using latent class analysis; (3) examine the role of contextual factors in driving syndemics and HIV prevention over time using multilevel regression models; (4) estimate HIV incidence in transgender women and examine the effect of syndemics and contextual factors on HIV incidence using Poisson regression models; and (5) develop dynamic, compartmental models of multilevel combination HIV prevention interventions among transgender women to simulate their impact on HIV incidence through 2030.

resultsEnrollment launched on March 15, 2023, with data collection phases occurring in spring and fall. As of February 24, 2024, a total of 3084 individuals were screened, and 996 (32.3%) met the inclusion criteria and enrolled into the cohort: 2.3% (23/996) enrolled at a hub, and 53.6% (534/996) enrolled through a community hub-supported strategy. Recruitment through purely digital methods contributed 61.5% (1895/3084) of those screened and 42.7% (425/996) of those enrolled in the cohort.

conclusionsStudy findings will inform the development of evidence-based interventions to reduce HIV acquisition and syndemic conditions among US transgender women and advance efforts to end the US HIV epidemic. Methodological findings will also have critical implications for the design of future innovative approaches to HIV research. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/59846.

Indexed as

HIV InfectionsTransgender PersonsAdolescentAdultCohort StudiesFemaleHumansIncidenceMaleRisk FactorsUnited StatesYoung Adultcohortdigital methodsHIVtransgender womenUnited States

Identifiers

PMID39190916
PMCPMC11387927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.